HIGHLIGHTS
- What: Frontiers in Molecular Biosciences frontiersin.org 10.3389/fmolb.2024.1407974 of this study is to examine the metabogram`s clinical potential in relation to revealing metabolic features and diagnosing early PD. The aim Frontiers in Molecular Biosciences The study cohort (see Section 2.1), which included control individuals and patients with early-stage PD, was used to obtain personal CBMs.
- Who: August et al. from the University of Salerno, Italy have published the research: August 2024 10.3389/fmolb.2024.1407974, in the Journal: (JOURNAL)
- How: The study was conducted in . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.